Avidity Biosciences, Inc.
RNA
$72.60
-$0.14-0.19%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
1/24/2026
-
Tickeron - Technical Analysis
1/24/2026
-
MarketBeat
1/23/2026
-
MarketBeat
1/23/2026
-
MarketBeat
1/23/2026
-
MarketBeat
1/23/2026
-
MarketBeat
1/23/2026
-
MarketBeat
1/23/2026
-
MarketBeat
1/22/2026
-
MarketBeat
1/22/2026
-
Tickeron - Stocks
1/22/2026
-
Zacks Investment Research
1/22/2026
-
GuruFocus
1/21/2026
-
Tickeron - Stocks
1/20/2026
-
GuruFocus
1/15/2026
-
MarketBeat
1/12/2026
-
MarketBeat
1/10/2026
-
MarketBeat
1/9/2026
-
MarketBeat
1/9/2026
-
MarketBeat
1/9/2026
-
MarketBeat
1/9/2026
-
MarketBeat
1/9/2026
-
MarketBeat
1/9/2026
-
MarketBeat
1/9/2026
-
MarketBeat
Avidity Biosciences (RNA, $72.37) Stochastic Oscillator left the overbought zone on January 08, 2026
1/9/2026
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, November 10, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 401 7900
Address
3020 Callan Road
San Diego, CA 92121
San Diego, CA 92121
Country
Year Founded
Business Description
Sector
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs). Its AOC platform is designed to combine the...
more